PGP and cancer: Furthermore, CDPDP has revealed that it is not a P-gp (P-glycoprotein) substrate; therefore, CDPDP is not susceptible to the efflux mechanism of P-gp, and many cancer cell lines utilize that as a drug resistance mechanism.